Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Sarfez Pharmaceuticals
Sarfez Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Soaanz
Torsemide
2021-06-14
2033
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Torsemide
therapeutic equivalency
,
type 2 diabetes mellitus
,
diabetes mellitus
,
biotransformation
,
food-drug interactions
,
body weight changes
,
lecithin cholesterol acyltransferase deficiency
,
fasting
,
pre-eclampsia
,
overactive urinary bladder
,
urinary incontinence
,
healthy volunteers/patients
,
genetic predisposition to disease
,
heart failure
,
hypertension
,
edema
,
chronic renal insufficiency
,
renal insufficiency
,
kidney diseases
,
cardiovascular diseases
,
tricuspid valve insufficiency
,
water intoxication
,
iron overload
,
hypernatremia
,
congenital heart defects
,
mitral valve insufficiency
,
covid-19
,
drug-related side effects and adverse reactions
,
drug interactions
,
aortic valve stenosis
Aspartame
myeloid leukemia acute
,
lymphoma
,
t-cell lymphoma
,
t-cell lymphoma peripheral
,
t-cell lymphoma cutaneous
,
multiple myeloma
,
plasma cell neoplasms
Spirolactone
heart failure
,
drug-related side effects and adverse reactions
Histone-arginine methyltransferase carm1
dry eye syndromes
,
macular degeneration
,
intravitreal injections
,
endophthalmitis
,
refractive errors
,
keratoconjunctivitis sicca
,
meibomian gland dysfunction
Surlorian
healthy volunteers/patients
,
lymphoma
,
follicular lymphoma
,
large b-cell lymphoma diffuse
,
non-hodgkin lymphoma
,
uterine cervical neoplasms
,
breast neoplasms
,
liver neoplasms
,
lung neoplasms
,
non-small-cell lung carcinoma
,
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
diabetes mellitus
,
rheumatoid arthritis
,
kidney diseases
,
kidney transplantation
,
carcinoma
,
thrombosis
,
hepatocellular carcinoma
,
exanthema
,
esophageal neoplasms
,
biliary tract neoplasms
,
hiv infections
,
castration-resistant prostatic neoplasms
,
obesity
,
overweight
,
type 2 diabetes mellitus
,
neoplasms
,
brain neoplasms
,
hematologic neoplasms
,
lymphoproliferative disorders
,
neoplasms by histologic type
,
neoplasms by site
,
multiple myeloma
,
plasma cell neoplasms
,
colorectal neoplasms
,
glioblastoma
,
disability evaluation
,
cognition disorders
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
chronic hepatitis
,
exercise
,
multiple sclerosis
,
sclerosis
,
papillomavirus infections
,
papillomaviridae
Isoxaflutole
food-drug interactions
,
heart failure
,
chronic renal insufficiency
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use